AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
919 total articles
Set up an RSS feed
Journal of Clinical Pathology back issues
Gene expression profiles in gastrointestinal stromal tumours.(Echo)
March 1, 2004... Initial clinical features and histopathology often fail to distinguish between benign and malignant gastrointestinal stromal tumours (GISTs). These tumours probably originate in the intestinal stem cells of Cajal and it is not possible to compare gene expression profiles of the malignant...
Reflective testing: providing added value.(Reflective Testing)
March 1, 2004... The processing of chemical pathology requests includes pre-analytical, analytical, and post-analytical phases. At its most basic, the post-analytical process is the reporting and delivery of validated results. One of the ways in which the chemical pathology laboratory provides "added value"...
The Journal of Clinical Pathology: quo vadis?(The Journal of Clinical Pathology)
March 1, 2004... "Idealism is what precedes experience; cynicism is what follows." David T Wolf (Born 1943). Although the new editorial team has been operating for the past 10 months, it is only now that they have really bedded down. I have deferred writing an editorial until a few key and pertinent...
Updated recommendations for HER2 testing in the UK.(Best Practice No 176)
March 1, 2004... This paper serves to update previously published guidance on rationale and methodology for HER2 laboratory testing following the recommendation for the use of HER2 targeted treatment in the management of advanced breast cancer in the UK. Emphasis is placed on the standardisation of...
My approach to oncocytic tumours of the thyroid.(Review)
March 1, 2004... The traditional approach to oncocytic thyroid lesions classified these as a separate entity, and applied criteria that are somewhat similar to those used for follicular lesions of the thyroid. In general, the guidelines to distinguish hyperplasia from neoplasia, and benign from malignant...